Search
for
Sort by
Research 31–60 of 1000+
- Persistent hair growth during treatment with the EGFR inhibitor erlotinib
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- Cutaneous Side Effects of Chemotherapy and Radiotherapy
- Adverse Hair Reactions to New Targeted Therapies for Cancer
- Skin toxicity induced by chemotherapy or molecular targeted therapy combined with immune checkpoint inhibitors in Asian patients: A literature review by the Japanese Pharmacist-led Oncodermatology Study Team
- Redefining hormone resistance in prostate cancer
- Evolving CRBN ligands enhance the drug-like properties of protein degraders
- TGF-β Family Signaling in Epithelial Differentiation and Epithelial–Mesenchymal Transition
- Novel acquisitions on the immunoprotective roles of the EGF receptor in the skin
- Erlotinib-Induced Skin Inflammation Is IL-1 Mediated in KC-Tie2 Mice and Human Skin Organ Culture
- Severe scarring alopecia associated with combinational use of ficlatuzumab and gefitinib: a clinical and immunohistochemistry study
- Mathematical Modeling and Inference of Epidermal Growth Factor-Induced Mitogen-Activated Protein Kinase Cell Signaling Pathways
- Transgenic mice provide new insights into the role of TGF-alpha during epidermal development and differentiation.
- The Cutaneous Epidermal Growth Factor Network: Can it be Translated Clinically to Stimulate Hair Growth?
- Cutaneous consequences of inhibiting EGF receptor signaling in vivo: Normal hair follicle development, but retarded hair cycle induction and inhibition of adipocyte growth in EgfrWa5 mice
- Cutaneous Lesions in the Rat Following Administration of an Irreversible Inhibitor of erbB Receptors, Including the Epidermal Growth Factor Receptor
- TCDD-induced activation of aryl hydrocarbon receptor regulates the skin stem cell population
- The trichoscopic features of hair shaft anomalies induced by epidermal growth factor receptor inhibitors: A case series
- Transcriptome analysis to identify the downstream genes of androgen receptor in dermal papilla cells
- The Cutaneous Epidermal Growth Factor Network: Can it be Translated Clinically to Stimulate Hair Growth? - eScholarship
- Epidermal Growth Factor Receptor Inhibitors: A Review of Cutaneous Adverse Events and Management
- The TRPM5 Antagonist Triphenylphosphine Oxide Increases Sebaceous Lipogenesis and Modulates Immune Phenotype of Human Sebocytes in a TRPM5‐Independent Manner
- Integrin signalling regulates YAP/TAZ to control skin homeostasis
- Epidermal Growth Factor as a Biologic Switch in Hair Growth Cycle
- Erlotinib-Associated Alopecia in a Lung Cancer Patient
- Directed Expression of Keratin 16 to the Progenitor Basal Cells of Transgenic Mouse Skin Delays Skin Maturation
- Genetically null mice reveal a central role for epidermal growth factor receptor in the differentiation of the hair follicle and normal hair development.
- Tumor Necrosis Factor-α and Interleukin-1 Antagonists Alleviate Inflammatory Skin Changes Associated with Epidermal Growth Factor Receptor Antibody Therapy in Mice
- The PDE4 inhibitor, apremilast, suppresses experimentally induced alopecia areata in human skin in vivo